Riskpilot← Back to searchSign inGet full accessBiosynex Nordic ApS
APSDissolvedCVR 38417541Strandvejen 100Diagnostic imaging services and medical laboratory activities · NACE 8691Est. 20172 employees
Revenue 2023
DKK -1,1M
-102% vs 2022
EBITDA margin
453.1%
-110% vs 2022
Equity ratio
-109.4%
Financial strength
Net profit 2023
DKK -3,9M
-109% vs 2022
| Revenue | DKK -1,1M | -102% |
| EBITDA | DKK -4,8M | -110% |
| Net profit | DKK -3,9M | -109% |
| Total assets | DKK 3,5M | -77% |
| Equity | DKK -3,8M | -3343% |
| Employees | 2 | — |
Legal name
Biosynex Nordic ApS
CVR number
38417541
Legal form
Anpartsselskab
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
9. februar 2017
Share capital
DKK 400.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af den administrerende direktør
Address
Strandvejen 100
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | 356 | -35 | 231 | 5.123 | 65.447 | 52.128 | -1.062 |
| Staff expenses | -0 | -0 | -0 | -0 | -862 | -1.912 | -3.750 |
| EBITDA | 1 | -35 | 231 | 5.123 | 64.584 | 50.216 | -4.812 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 1 | -35 | 231 | 5.123 | 64.584 | 50.216 | -4.812 |
| Net financials | 0 | -1 | -3 | -24 | -808 | 3.426 | -224 |
| Profit before tax | 1 | -36 | 228 | 5.099 | 63.776 | 53.642 | -5.035 |
| Tax | 0 | -6 | 50 | 1.124 | 14.048 | 11.840 | -1.104 |
| Net profit | 1 | -29 | 178 | 3.975 | 49.729 | 41.803 | -3.932 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Total assets | 331 | 283 | 504 | 11.023 | 99.029 | 15.082 | 3.487 |
| Equity | 51 | 21 | 199 | 4.175 | 40.129 | 118 | -3.814 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 2.966 | 0 |
| Short-term debt | 281 | 262 | 305 | 6.848 | 58.901 | 11.999 | 7.301 |
| Total debt | 281 | 262 | 305 | 6.848 | 58.901 | 14.964 | 7.301 |
EBITDA margin
-481158300.0%
This company
15.8%
Market median
-3045305796% vs market
20172023
Equity ratio
-109.4%
This company
38.2%
Market median
-386% vs market
20172023
Return on equity
-393179400.0%
This company
18.4%
Market median
-2136844665% vs market
20172023
Net profit margin
-393179400.0%
This company
8.1%
Market median
-4854066767% vs market
20172023
Asset turnover
-0.30×
This company
1.12×
Market median
-127% vs market
20172023
Debt / equity
1.91×
This company
0.62×
Market median
-208% vs market
20172023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-02-09 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
Jv Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10.0% | 10.0% | 2017 | |
ROSLYNG HOLDING ApS | Company | 5.0% | 5.0% | 2019 |
| Individual | 66.7% | 66.7% | 2018 | |
FLAGSTAD BUSINESS CONSULTANTS ApS | Company | 25.0% | 25.0% | 2017 |
| Individual | 100.0% | 100.0% | 2024 | |
| Individual | 10.0% | 10.0% | 2017 | |
BJØRKMANN ApS | Company | 25.0% | 25.0% | 2017 |
JOFFE CONSULT ApS | Company | 20.0% | 20.0% | 2022 |
HOLDINGSELSKABET 20.10.2010 ApS | Company | 20.0% | 20.0% | 2019 |
Turtle Consult ApS | Company | 5.0% | 5.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biosynex Nordic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Janus von Platen-Hallermund | Chief Executive Officer | 0 companies |
| Thierry Paper | Board of Directors | 0 companies |
| Michael Lexner | Board of Directors | 0 companies |
| Larry Abensur | Board of Directors | 0 companies |
| Jacques Cavadenti | Board of Directors | 0 companies |
| Thomas Lamy | Board of Directors | 0 companies |
| Finn Schwarz | Chairman | 0 companies |
| Michael Daugbjerg | Board of Directors | 0 companies |